| Phosphatidylserine receptors enhance SARS-CoV-2 infection D Bohan, H Van Ert, N Ruggio, KJ Rogers, M Badreddine, ... PLoS pathogens 17 (11), e1009743, 2021 | 74 | 2021 |
| Neutralization, effector function and immune imprinting of Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Nature 621 (7979), 592-601, 2023 | 51 | 2023 |
| IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection KJ Rogers, B Brunton, L Mallinger, D Bohan, KM Sevcik, J Chen, ... PLoS neglected tropical diseases 13 (12), e0007819, 2019 | 36 | 2019 |
| Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus CT Ekanger, F Zhou, D Bohan, ML Lotsberg, M Ramnefjell, L Hoareau, ... Frontiers in cellular and infection microbiology 12, 841447, 2022 | 24 | 2022 |
| Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants A Addetia, L Piccoli, JB Case, YJ Park, M Beltramello, B Guarino, H Dang, ... Biorxiv, 2023.01. 17.523798, 2023 | 22 | 2023 |
| Enveloped RNA virus utilization of phosphatidylserine receptors: Advantages of exploiting a conserved, widely available mechanism of entry D Bohan, W Maury PLoS pathogens 17 (9), e1009899, 2021 | 10 | 2021 |
| Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection KJ Rogers, O Shtanko, LL Stunz, LN Mallinger, T Arkee, ME Schmidt, ... Journal of Leucocyte Biology 109 (2), 309-325, 2021 | 10 | 2021 |
| Epitranscriptomic N6-Methyladenosine Profile of SARS-CoV-2-Infected Human Lung Epithelial Cells S Phillips, T Mishra, S Khadka, D Bohan, CE Espada, W Maury, L Wu Microbiology spectrum 11 (1), e03943-22, 2023 | 6 | 2023 |
| Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection D Bohan, H Van Ert, S Dhakal, N Ruggio, K Rogers, T Stokowy, ... Topics in Antiviral Medicine, 137-138, 2021 | 2 | 2021 |
| AXL as a therapeutic target in STK11 mutant NSCLC M Blø, A Rayford, N Madeleine, F Gärtner, D Bohan, N Ruggio, H Li, ... Cancer Research 83 (7_Supplement), 3245-3245, 2023 | 1 | 2023 |
| Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein HA Van Ert, DW Bohan, K Rogers, M Fili, RA Rojas Chávez, E Qing, ... Microbiology spectrum 10 (1), e02676-21, 2022 | 1 | 2022 |
| Optimizing immunoassay-based selection of donors for COVID-19 convalescent plasma HA Van Ert, K Rogers, D Bohan, C Han, S Dempewolf, K Sevcik, ... The Journal of Immunology 206 (1_Supplement), 30.16-30.16, 2021 | | 2021 |
| Phosphatidylserine Receptor Enhancement of SARS-CoV-2 Entry: AXL as a Therapeutic Target for COVID-19 D Bohan, H Van Ert, N Ruggio, K Rogers, T Stokowy, G Gausdal, ... Luminescence 10000, 20000, 2021 | | 2021 |
| CD40 signaling restricts RNA virus replication in macrophages, leading to rapid innate immune control of acute virus infection KJ Rogers, O Shtanko, LL Stunz, LN Mallinger, T Arkee, ME Schmidt, ... Journal of leukocyte biology 109 (2), 309, 2021 | | 2021 |
| Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 (preprint) D Bohan, HV Ert, N Ruggio, KJ Rogers, M Badreddine, JA Aguilar Briseno, ... | | 2021 |
| Investigating early events during enveloped RNA virus infection: understanding cell tropism, routes of infection and virus utilization of cellular receptors D Bohan University of Iowa, 0 | | |
